Avicenna’s expertise in evaluating new chemical entities / new biological entities can be accessed by pharmaceutical and biotech companies who are seeking due-diligence and valuation of their compounds under development. Additionally, Avicenna’s network of product “scouts” can help you locate NCEs / NBEs that can complement your existing pipeline. And if you are looking for an independant confidante who can help you structure and manage licensing deals, then Avicenna is the one you are looking for.